The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.
The aim of the GMALL registry is to collect data on the diagnosis, treatment and disease progression of ALL in patients 18 years of age with no upper age limit in routine clinical practice, regardless of whether the patient is being treated within a clinical therapy trial or not.
